Glutamate-evoked calcium signaling in spinal cord after nerve injury

神经损伤后脊髓中谷氨酸诱发的钙信号传导

基本信息

  • 批准号:
    8536968
  • 负责人:
  • 金额:
    $ 7.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A fundamental gap exists in understanding the cellular mechanisms that initiate and maintain neuropathic pain. This gap represents an important problem because current analgesic drugs rarely provide sufficient efficacy without serious side effects. The long-term goal is to understand the mechanisms that lead to injury-induced central sensitization and establish clinically relevant therapeutic targets for chronic pai. The objective in this application is to evaluate the contribution glutamate receptor subtypes to dorsal root stimulation (DRS)-evoked Ca2+ transients in the dorsal horn, and correlate enhanced Ca2+ responses with the magnitude of pain-like behavior. Based on preliminary data suggesting that glutamate-evoked Ca2+ responses in mouse spinal cord slices are potentiated after nerve injury, the central hypothesis is that nerve injury increases AMPA receptor signaling in the dorsal horn, leading to increases in [Ca2+]i that results in central sensitization and neuropathic pain. The rationale for the proposed project is that [Ca2+]i in dorsal horn neurons is essential for central sensitization and pain hypersensitivity. The central hypothesis will be teste by pursuing three specific aims: AIM 1 tests the hypothesis that glutamate-mediated activation of neuronal ionotropic AMPA receptors drives Ca2+ signaling. Electrophysiological recordings and real-time fluorescent labeling of astrocytes will be used to evaluate the cell types that respond to dorsal root stimulation (DRS) with a rise in [Ca2+]i. Next, the relative contribution of glutamate receptor subtypes will be determined by quantifying DRS-evoked [Ca2+]i transients in the presence of selective antagonists. AIM 2 tests the hypothesis that peripheral nerve injury potentiates DRS-evoked Ca2+ responses, and this will correlate with the magnitude of hyperalgesia. To allow for a correlation analysis between behavior and [Ca2+]i, a variant model of nerve injury has been developed that gradually elicits robust allodynia in 1 week and then resolves in 4 weeks. Behavioral hyperalgesia will be evaluated and compared to DRS-evoked [Ca2+]i in spinal cord slices from sham, traditional and variant nerve injured animals sacrificed at 7, 14 and 21 d after injury. AIM 3 tests the hypothesis that PKM¿ mediates SNI-induced increases in hyperalgesia, Ca2+ signaling and AP frequency in dorsal horn. We will administer multiple PKM¿ inhibitors to sham and SNI mice and measure pain- like behavior, Ca2+ transients and/or AP frequency. Based on our preliminary results, we predict that PKM¿ blockade will reverse injury-induced hyperalgesia, increases in [Ca2+]i and AP frequency. This project employs innovative wide-field calcium imaging simultaneously from numerous cells in spinal cord slices from adult mice. The proposed research is significant because it reveals the Ca2+ channels that regulate DRS-evoked Ca2+ transients, and is a critical first step in understanding nerve injury-induced potentiation of neuronal Ca2+ signaling. Ultimately, this knowledge will establish clinically relevant therapeutic targets for alleviating chronic pain.
描述(由申请人证明):理解引发和维持神经性疼痛的细胞机制,因为当前的药物重新提供了副作用。在此应用中,安属 - 建立the脚的豆胶PAI。表明在小鼠脊髓切片中诱发的谷氨酸诱发的Ca2+ respon+ respon+ respon+ respon+ respon+ ses被增强,中心假设是在背角中的神经增加的受体信号。疼痛。在背角神经元中尤其是中心。刺激(drs),下一个i。 谷氨酸受体亚型将通过在存在选择性拮抗剂的情况下量化DRS诱发的[Ca2+] i的转移。相关性分析行为和[Ca2+] I,已经开发了一种神经的变异模型,可在1周内引起健壮的ODYNIA,然后在4周内消退。 tpkm¿介导SNI诱导率增加了Hypergeria,Ca2+信号传导和AP频率。对假ANI小鼠的抑制剂测量疼痛样行为,Ca2+瞬态和/或AP在PKM缺封锁会造成损伤引起的高温,[CA2+] I和AP频率同时从成年小鼠的脊髓中同时衰老。将建立与临床相关的治疗靶标,以减轻疼痛。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Suzanne Doolen其他文献

Suzanne Doolen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Suzanne Doolen', 18)}}的其他基金

Glutamate Receptor Modulation of Calcium Signaling in Neuropathic Pain
神经性疼痛中钙信号传导的谷氨酸受体调节
  • 批准号:
    8792377
  • 财政年份:
    2014
  • 资助金额:
    $ 7.17万
  • 项目类别:
Glutamate Receptor Modulation of Calcium Signaling in Neuropathic Pain
神经性疼痛中钙信号传导的谷氨酸受体调节
  • 批准号:
    8580803
  • 财政年份:
    2014
  • 资助金额:
    $ 7.17万
  • 项目类别:
Glutamate Receptor Modulation of Calcium Signaling in Neuropathic Pain
神经性疼痛中钙信号传导的谷氨酸受体调节
  • 批准号:
    8997069
  • 财政年份:
    2014
  • 资助金额:
    $ 7.17万
  • 项目类别:
Spinal AMPA receptors, latent central sensitization and chronic pain
脊髓 AMPA 受体、潜在中枢敏化和慢性疼痛
  • 批准号:
    8772240
  • 财政年份:
    2014
  • 资助金额:
    $ 7.17万
  • 项目类别:
Glutamate-evoked calcium signaling in spinal cord after nerve injury
神经损伤后脊髓中谷氨酸诱发的钙信号传导
  • 批准号:
    8445756
  • 财政年份:
    2012
  • 资助金额:
    $ 7.17万
  • 项目类别:

相似国自然基金

ABHD6与AMPA受体结合位点的鉴定及该位点在AMPA受体转运和功能调控中的作用研究
  • 批准号:
    32300794
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
AMPA受体正向变构调节剂快速抗抑郁作用及其神经机制研究
  • 批准号:
    82371524
  • 批准年份:
    2023
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目
SNX32棕榈酰化修饰调控AMPA受体介导的突触可塑性在AD中的作用机制
  • 批准号:
    32360219
  • 批准年份:
    2023
  • 资助金额:
    35 万元
  • 项目类别:
    地区科学基金项目
翻译水平选择性调控皮层AMPA受体表达促进神经元形态功能发育及神经环路塑造的分子机制及生理功能研究
  • 批准号:
    32360194
  • 批准年份:
    2023
  • 资助金额:
    31 万元
  • 项目类别:
    地区科学基金项目
基于奖赏环路内AMPA受体相关的突触可塑性变化探讨痫蛋白在抑郁症发病中的作用及机制
  • 批准号:
    82360277
  • 批准年份:
    2023
  • 资助金额:
    32.2 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Mechanisms of Hypoxia-Mediated Disturbances in Cerebral Maturation in a Fetal Ovine Model of Maternal Sleep Apnea
母体睡眠呼吸暂停胎羊模型中缺氧介导的大脑成熟障碍的机制
  • 批准号:
    10608612
  • 财政年份:
    2023
  • 资助金额:
    $ 7.17万
  • 项目类别:
Elucidating the dynamic role of PTPsigma in synaptic nano-organization and NMDA receptor function
阐明 PTPsigma 在突触纳米组织和 NMDA 受体功能中的动态作用
  • 批准号:
    10606077
  • 财政年份:
    2023
  • 资助金额:
    $ 7.17万
  • 项目类别:
VMH SF1 neurons-originated sympathetic circuits modulating iWAT and iBAT
VMH SF1 神经元起源的交感神经回路调节 iWAT 和 iBAT
  • 批准号:
    10635521
  • 财政年份:
    2023
  • 资助金额:
    $ 7.17万
  • 项目类别:
MMP-9 activity modulates sharp wave ripple events in the zebrafish hippocampus leading to cognitive deficits
MMP-9 活性调节斑马鱼海马中的尖锐波涟漪事件,导致认知缺陷
  • 批准号:
    10386410
  • 财政年份:
    2022
  • 资助金额:
    $ 7.17万
  • 项目类别:
Prefrontal cellular and circuitry mechanisms in a mouse model of C9ORF72-associated frontotemporal dementia.
C9ORF72 相关额颞叶痴呆小鼠模型中的前额细胞和电路机制。
  • 批准号:
    9760186
  • 财政年份:
    2019
  • 资助金额:
    $ 7.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了